Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Global Ship Lease declares quarterly dividend of $0.546875 per preferred share for Q2 2026.

Company Fundamentals
08 Jun 2026
Na
View Source
Neutral
pluang ai news

Global Ship Lease, a containership owner, announced a quarterly cash dividend of $0.546875 per depositary share for its 8.75% Series B Preferred Shares, covering April to June 2026. The dividend will be paid on July 1, 2026, to shareholders recorded by June 24, 2026. As of March 31, 2026, the company’s fleet had an average charter term of 2.6 years with contracted revenue of $2.05 billion, highlighting stable future income. This dividend reflects the company's ongoing commitment to returning value to preferred shareholders amid steady operational performance.

More News

DBV Technologies revises participation at Goldman Sachs Global Healthcare Conference due to CEO travel issue.

DBV Technologies revises participation at Goldman Sachs Global Healthcare Conference due to CEO travel issue.

DBV Technologies announced a change in its participation at the 47th Annual Global Healthcare Conference by Goldman Sachs, held on June 9, 2026, in Miami. The company's CEO, Daniel Tassé, will not attend the informal discussion as initially planned d...

Market News
Neutral
19 minutes ago
Revenium launches AI Insights to identify and fix costly AI budget waste for enterprises.

Revenium launches AI Insights to identify and fix costly AI budget waste for enterprises.

Revenium introduced AI Insights, a tool that analyzes enterprise AI usage to pinpoint and rank budget waste, linking each issue to specific transactions for easy fixes. This helps companies recover costs by identifying inefficiencies like outdated mo...

Others
Neutral
19 minutes ago
Antag Therapeutics appoints Keith Leonard as new Chairman to advance obesity drug AT7687.

Antag Therapeutics appoints Keith Leonard as new Chairman to advance obesity drug AT7687.

Antag Therapeutics has elected Keith Leonard as Chairman of its Board of Directors to support the development of its obesity treatment drug, AT7687. Leonard brings 30 years of biopharmaceutical leadership experience, including roles as CEO and Chairm...

Company Fundamentals
Bullish
19 minutes ago
MitoRx appoints new CFO, CMO, and director to advance obesity drug MTRX31 into clinical trials

MitoRx appoints new CFO, CMO, and director to advance obesity drug MTRX31 into clinical trials

MitoRx Therapeutics has strengthened its leadership team by appointing Alison Strutt as CFO, László Tankó as Consultant CMO, and Sam Fazeli as Non-Executive Director. These hires come as MitoRx prepares to advance its lead drug candidate, MTRX31, a n...

Company Fundamentals
Bullish
19 minutes ago
HR Tech 2026 unveils agenda focused on AI-driven HR transformation and workforce skills development.

HR Tech 2026 unveils agenda focused on AI-driven HR transformation and workforce skills development.

HR Tech 2026, scheduled for October 20-22 in Las Vegas, announced its agenda centered on real-world AI implementation, workforce skills, and HR transformation. The event features sessions from leaders at major companies like IFF, Lumen, and Sanofi, c...

Others
Bullish
19 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App